NASDAQ:ATRA

Atara Biotherapeutics Stock Predictions

Healthcare > Biotechnology

Buy ATRA

*Your capital is at risk

$9.63

-0.270 (-2.73%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ATRA Prediction Chart

ATRA Predictions History

Latest community submissions for ATRA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Cherie Lynn Auletta @CherieLynnAuletta.210168	Jul 7, 2021	Bullish	$14.59	X	—	1
mminvestment	Jul 7, 2021	Bullish	$14.59	X	—	0
NameNotImportant Pro	Apr 29, 2019	$34.42 -96.03%	$34.70	X	99.19%	2
JS Pro	Jan 16, 2018	$26.67 -96.13%	$28.25	V	94.40%	0
bbullish2 Merchant @bbullish2.7792	Jan 16, 2018	$24.94 -96.38%	$28.25	V	88.30%	0
JS Pro	Sep 15, 2017	$15.40 -96.06%	$15.65	V	98.40%	0
Donnie.Bean.11788	Sep 15, 2017	$15.54 -96.03%	$15.65	X	99.30%	3
JS Pro	Apr 19, 2017	$18.47 -96.00%	$18.45	X	99.90%	5
JS Pro	Mar 14, 2017	$22.01 -95.64%	$20.20	V	91.00%	0
Jack.Cesario.Migueis.3576 Amateur	Mar 14, 2017	$20.37 -95.97%	$20.20	V	99.20%	2

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ATRA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ATARA BIOTHERAPEUTICS

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by